OFLOMED

This brand name is authorized in Nigeria. It is also authorized in Tunisia.

Active ingredients

The drug OFLOMED contains one active pharmaceutical ingredient (API):

1	Ofloxacin UNII A4P49JAZ9H - OFLOXACIN
	Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.
	Read more about Ofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3132	Tablet	Oflomed Tablet 200 mg TAB 200 mg		20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-3132
TN	Direction de la Pharmacie et du Médicament	9093311, 9093312